Last Updated: November 16, 2026

Investigational Drug Information for Fallypride

« Back to Dashboard


What is the development status for investigational drug Fallypride?

Fallypride is an investigational drug.

There have been 19 clinical trials for Fallypride. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2005.

The most common disease conditions in clinical trials are Schizophrenia, Alcoholism, and Obesity. The leading clinical trial sponsors are National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Emory University, and University of California, Irvine.

Recent Clinical Trials for Fallypride
TitleSponsorPhase
Neurobiological Mechanisms of Pathological Rumination and Effects of AripiprazoleNational Natural Science Foundation of ChinaNA
Neurobiological Mechanisms of Pathological Rumination and Effects of AripiprazoleSecond Xiangya Hospital of Central South UniversityNA
Neurobiological Mechanisms of Pathological Rumination and Effects of AripiprazoleCentral South UniversityNA

See all Fallypride clinical trials

Clinical Trial Summary for Fallypride

Top disease conditions for Fallypride
Top clinical trial sponsors for Fallypride

See all Fallypride clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.